Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA ZYDUS LIFESCIENCES ASTRAZENECA PHARMA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 91.1 20.1 452.6% View Chart
P/BV x 16.5 2.4 688.6% View Chart
Dividend Yield % 0.3 0.6 47.9%  

Financials

 ASTRAZENECA PHARMA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-22
ZYDUS LIFESCIENCES
Mar-22
ASTRAZENECA PHARMA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs4,580674 679.8%   
Low Rs2,529331 764.0%   
Sales per share (Unadj.) Rs322.2149.1 216.1%  
Earnings per share (Unadj.) Rs24.622.7 108.4%  
Cash flow per share (Unadj.) Rs31.429.7 105.8%  
Dividends per share (Unadj.) Rs10.002.50 400.0%  
Avg Dividend yield %0.30.5 56.5%  
Book value per share (Unadj.) Rs203.8166.1 122.7%  
Shares outstanding (eoy) m25.001,023.74 2.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x11.03.4 327.4%   
Avg P/E ratio x144.322.1 652.6%  
P/CF ratio (eoy) x113.116.9 668.6%  
Price / Book Value ratio x17.43.0 576.6%  
Dividend payout %40.611.0 368.9%   
Avg Mkt Cap Rs m88,863514,277 17.3%   
No. of employees `000NANA-   
Total wages/salary Rs m2,30221,777 10.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m8,056152,652 5.3%  
Other income Rs m1482,354 6.3%   
Total revenues Rs m8,204155,006 5.3%   
Gross profit Rs m86234,427 2.5%  
Depreciation Rs m1707,130 2.4%   
Interest Rs m101,270 0.7%   
Profit before tax Rs m83028,381 2.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2145,117 4.2%   
Profit after tax Rs m61623,264 2.6%  
Gross profit margin %10.722.6 47.4%  
Effective tax rate %25.818.0 143.2%   
Net profit margin %7.615.2 50.2%  
BALANCE SHEET DATA
Current assets Rs m7,653122,614 6.2%   
Current liabilities Rs m3,92378,394 5.0%   
Net working cap to sales %46.329.0 159.8%  
Current ratio x2.01.6 124.7%  
Inventory Days Days6193 66.1%  
Debtors Days Days3980 48.7%  
Net fixed assets Rs m2,120144,382 1.5%   
Share capital Rs m501,024 4.9%   
"Free" reserves Rs m5,044168,972 3.0%   
Net worth Rs m5,094169,996 3.0%   
Long term debt Rs m03,621 0.0%   
Total assets Rs m9,773266,996 3.7%  
Interest coverage x88.423.3 378.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.6 144.2%   
Return on assets %6.49.2 69.7%  
Return on equity %12.113.7 88.4%  
Return on capital %16.517.1 96.5%  
Exports to sales %00-   
Imports to sales %31.714.3 221.1%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m2,55221,869 11.7%   
Fx inflow Rs m44263,065 0.7%   
Fx outflow Rs m2,55221,869 11.7%   
Net fx Rs m-2,11041,196 -5.1%   
CASH FLOW
From Operations Rs m1,00821,041 4.8%  
From Investments Rs m4711,544 0.4%  
From Financial Activity Rs m-95-8,683 1.1%  
Net Cashflow Rs m96123,729 4.0%  

Share Holding

Indian Promoters % 0.0 75.0 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 15.5 24.5%  
FIIs % 2.5 2.6 95.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 25.0 99.9%  
Shareholders   49,085 408,231 12.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on ASTRAZENECA PHARMA vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Cadila Healthcare Share Price Performance

Period ASTRAZENECA PHARMA Cadila Healthcare S&P BSE HEALTHCARE
1-Day -0.13% 2.28% 0.33%
1-Month 7.64% -3.70% 0.28%
1-Year 10.48% -13.04% -6.55%
3-Year CAGR 7.06% 16.15% 20.31%
5-Year CAGR 24.02% -1.98% 10.96%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 40.6%.

Cadila Healthcare paid Rs 2.5, and its dividend payout ratio stood at 11.0%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 21 Points Higher | BHEL, RVNL Surge 10% to Hit 52-Week High | Why PNB Share Price is Rising(Closing)

Indian share markets traded in a rangebound manner throughout today's session to end flat.